Opt-in versus universal codeine provision for medical abortion up to 10 weeks of gestation at British Pregnancy Advisory Service: a cross-sectional evaluation.
Neda TaghinejadiHannah McCullochMichal KrassowskiAmelia McInnes-DeanKatherine C WhitehousePatricia A LohrPublished in: BMJ sexual & reproductive health (2024)
Our findings suggest that patients have a better experience with pain management during medical abortion when able to opt-in to codeine provision following counselling versus receiving this medication routinely.
Keyphrases
- pain management
- healthcare
- end stage renal disease
- ejection fraction
- palliative care
- newly diagnosed
- chronic pain
- chronic kidney disease
- mental health
- preterm infants
- gestational age
- preterm birth
- prognostic factors
- patient reported outcomes
- smoking cessation
- human immunodeficiency virus
- pregnancy outcomes
- antiretroviral therapy
- hiv testing